Trademarkia Logo

Canada

C$
Trademark Search in Canada
TYBONDRY

View On IC.GC.CA

TYBONDRY
ABANDONED SECTION 36

on 23 Oct 2024

Last Applicant/ Owned by

BRIDGEBIO PHARMA INC.

3160 Porter Dr., Suite 250 Palo Alto CA 94304

US

Serial Number

2235720 filed on 21st Dec 2022

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

TYBONDRY

Trademark usage description

pharmaceuticals for use in the treatment of oncological, cardiological, dermatological, neurological, genetic, orthopedic and metabolic diseases and d Read More

Classification Information

Class [005]
Pharmaceuticals for use in the treatment of oncological, cardiological, dermatological, neurological, genetic, orthopedic and metabolic diseases and disorders.

Classification kind code

11

Mark Details

Serial Number

2235720

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 135
on 14th Mar 2024		Amendment to Application
Submitted for opposition 22
on 16th Jan 2024		Search Recorded
Submitted for opposition 20
on 16th Jan 2024		Examiner's First Report
Submitted for opposition 223
on 16th Jan 2024		Total Provisional Refusal
Submitted for opposition 256
on 27th Nov 2023		Notification of Possible Opposition Sent
Submitted for opposition 257
on 26th Jan 2023		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 25th Jan 2023		Created
Submitted for opposition 31
on 25th Jan 2023		Formalized
Submitted for opposition 30
on 21st Dec 2022		Filed
Submitted for opposition 228
on 21st Dec 2022		International Registration